Selection dramatically reduces effective population size in HIV-1 infection

被引:18
|
作者
Liu, Yi [1 ]
Mittler, John E. [1 ]
机构
[1] Univ Washington, Sch Med, Dept Microbiol, Seattle, WA 98195 USA
关键词
D O I
10.1186/1471-2148-8-133
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Background: In HIV-1 evolution, a 100-100,000 fold discrepancy between census size and effective population size (N(e)) has been noted. Although it is well known that selection can reduce N(e), high in vivo mutation and recombination rates complicate attempts to quantify the effects of selection on HIV-1 effective size. Results: We use the inbreeding coefficient and the variance in allele frequency at a linked neutral locus to estimate the reduction in N(e) due to selection in the presence of mutation and recombination. With biologically realistic mutation rates, the reduction in Ne due to selection is determined by the strength of selection, i. e., the stronger the selection, the greater the reduction. However, the dependence of Ne on selection can break down if recombination rates are very high ( e. g., r >= 0.1). With biologically likely recombination rates, our model suggests that recurrent selective sweeps similar to those observed in vivo can reduce within-host HIV-1 effective population sizes by a factor of 300 or more. Conclusion: Although other factors, such as unequal viral reproduction rates and limited migration between tissue compartments contribute to reductions in Ne, our model suggests that recurrent selection plays a significant role in reducing HIV-1 effective population sizes in vivo.
引用
收藏
页数:11
相关论文
共 50 条
  • [31] Intrafamilial transmission of HIV-1 infection from individuals with unrecognized HIV-1 infection
    French, MA
    Herring, BL
    Kaldor, JM
    Sayer, DC
    Furner, V
    de Chaneet, CC
    Dwyer, DE
    AIDS, 2003, 17 (13) : 1977 - 1981
  • [32] Ambiguity in population-based sequencing of HIV-1 as a marker for the age of HIV infection
    Kouyos, R. D.
    von Wyl, V.
    Yerly, S.
    Boeni, J.
    Rieder, P.
    Joos, B.
    Taffe, P.
    Shah, C.
    Buergisser, P.
    Klimkait, T.
    Weber, R.
    Hirschel, B.
    Cavassini, M.
    Rauch, A.
    Battegay, M.
    Vernazza, P. L.
    Bernasconi, E.
    Ledergerber, B.
    Bonhoeffer, S.
    Guenthard, H. F.
    ANTIVIRAL THERAPY, 2010, 15 : A158 - A158
  • [33] Frequency of occurrence of HIV-1 dual infection in a Belgian MSM population
    Hebberecht, Laura
    Vancoillie, Leen
    Schauvliege, Marlies
    Staelens, Delfien
    Dauwe, Kenny
    Mortier, Virginie
    Verhofstede, Chris
    PLOS ONE, 2018, 13 (04):
  • [34] Immunotherapies in HIV-1 infection
    Pett, Sarah L.
    CURRENT OPINION IN HIV AND AIDS, 2009, 4 (03) : 188 - 193
  • [35] SINUSITIS IN HIV-1 INFECTION
    ZURLO, JJ
    FEUERSTEIN, IM
    LEBOVICS, R
    LANE, HC
    AMERICAN JOURNAL OF MEDICINE, 1992, 93 (02): : 157 - 162
  • [36] THE NEUROPATHOGENESIS OF HIV-1 INFECTION
    GENDELMAN, HE
    LIPTON, SA
    TARDIEU, M
    BUKRINSKY, MI
    NOTTET, HSLM
    JOURNAL OF LEUKOCYTE BIOLOGY, 1994, 56 (03) : 389 - 398
  • [37] Neopterin in HIV-1 infection
    Wirleitner, B
    Schroecksnadel, K
    Winkler, C
    Fuchs, D
    MOLECULAR IMMUNOLOGY, 2005, 42 (02) : 183 - 194
  • [38] Associations of IFN-γ polymorphism with HIV-1 infection in the Korean population
    Kang, MW
    Pyo, CW
    Wie, SH
    Choi, HB
    Kim, Y
    Kim, YK
    Lee, JS
    Kim, TG
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 2006, 22 (03) : 297 - 299
  • [39] RESISTANCE TO HIV-1 INFECTION
    DETELS, R
    LIU, ZY
    HENNESSEY, K
    KAN, JL
    VISSCHER, BR
    TAYLOR, JMG
    HOOVER, DR
    RINALDO, CR
    PHAIR, JP
    SAAH, AJ
    GIORGI, JV
    JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES AND HUMAN RETROVIROLOGY, 1994, 7 (12): : 1263 - 1269
  • [40] The pathogenesis of HIV-1 infection
    Weber, J
    BRITISH MEDICAL BULLETIN, 2001, 58 : 61 - 72